HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Senegal
Senegal: HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate was 0.3112 % change on previous year in 2024. ◆ Volatile
HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Senegal, 2001–2024
Source: Statizoid (derived). Measured in % change on previous year.
Analysis
The most recent figure for hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Senegal is 0.3112 % change on previous year, measured in 2024.
The figure is up 16.9% on the previous year and down 83.1% over ten years.
Over the whole period, hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Senegal peaked at 491.36 % change on previous year in 2001 and was at its lowest, -16.84 % change on previous year, in 2003.
Senegal ranks 100th of 157 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Senegal, year by year
| Year | % change on previous year | Change |
|---|---|---|
| 2001 | 491.36 % change on previous year | — |
| 2002 | 140.26 % change on previous year | -71.5% |
| 2003 | -16.84 % change on previous year | -112.0% |
| 2004 | -13.06 % change on previous year | -22.5% |
| 2005 | -4.9 % change on previous year | -62.5% |
| 2006 | 6.04 % change on previous year | -223.4% |
| 2008 | 80.49 % change on previous year | +1232.0% |
| 2009 | 7.14 % change on previous year | -91.1% |
| 2010 | 0.699 % change on previous year | -90.2% |
| 2011 | -2.65 % change on previous year | -479.1% |
| 2012 | -7.65 % change on previous year | +188.9% |
| 2013 | -7.96 % change on previous year | +4.0% |
| 2014 | 1.84 % change on previous year | -123.2% |
| 2015 | 2.27 % change on previous year | +22.9% |
| 2016 | 3.86 % change on previous year | +70.2% |
| 2017 | 3.41 % change on previous year | -11.7% |
| 2018 | 3.73 % change on previous year | +9.5% |
| 2019 | 4.03 % change on previous year | +7.8% |
| 2020 | 3.49 % change on previous year | -13.2% |
| 2021 | 0.8197 % change on previous year | -76.5% |
| 2022 | -0.1575 % change on previous year | -119.2% |
| 2023 | 0.2663 % change on previous year | -269.1% |
| 2024 | 0.3112 % change on previous year | +16.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 86.31 % change on previous year | -16.84 % change on previous year | 491.36 % change on previous year | 8 |
| 2010s | 0.157 % change on previous year | -7.96 % change on previous year | 4.03 % change on previous year | 10 |
| 2020s | 0.9464 % change on previous year | -0.1575 % change on previous year | 3.49 % change on previous year | 5 |
Countries ranked near Senegal
- 97 Greece 0.6657 % change on previous year compare
- 98 Liberia 0.5088 % change on previous year compare
- 99 Côte d'Ivoire 0.5063 % change on previous year compare
- 101 Portugal 0.2873 % change on previous year compare
- 102 Guinea-Bissau 0.1892 % change on previous year compare
- 103 Malaysia 0.1484 % change on previous year compare
More health data for Senegal
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7598 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 835.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,496 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate 2.42 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0658 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.29 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Senegal?
- Hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Senegal was 0.3112 % change on previous year in 2024, according to Statizoid (derived).
- What is the highest hiv/aids deaths averted by antiretroviral therapy, annual growth rate recorded in Senegal?
- The highest recorded value was 491.36 % change on previous year in 2001.
- What is the lowest hiv/aids deaths averted by antiretroviral therapy, annual growth rate recorded in Senegal?
- The lowest recorded value was -16.84 % change on previous year in 2003.
- How does Senegal rank for hiv/aids deaths averted by antiretroviral therapy, annual growth rate?
- Senegal ranks 100th out of 157 countries with data for 2024.
- Is hiv/aids deaths averted by antiretroviral therapy, annual growth rate rising or falling in Senegal?
- Over the last ten years it is down 83.1%. The long-run trend across the full record is volatile.
- Where does this Senegal data come from?
- The figures come from Statizoid (derived), published as part of HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under Derived by Statizoid from the sources named on the page.
How this figure is calculated
The year-on-year percentage change in HIV/AIDS deaths averted by antiretroviral therapy. Computed from consecutive annual observations; years either side of a gap are skipped rather than bridged.
Computed from
- HIV/AIDS deaths averted by antiretroviral therapy Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Statizoid computes this series; the underlying measurements belong to the publishers named above. The arithmetic is applied to every country and year where both inputs report, and nothing is estimated unless the page says so.
About this data
The year-on-year percentage change in HIV/AIDS deaths averted by antiretroviral therapy. Computed from consecutive annual observations; years either side of a gap are skipped rather than bridged.